Global IDO Inhibitors Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI534846
  • May 03, 2019
  • Global
  • 91 pages
  • QY Market Research
                                          

"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the IDO Inhibitors market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the IDO Inhibitors market." The IDO (indoleamine 2,3-dioxygenase 1, IDO1, IDO-1, INDO, indoleamine-pyrrole 2,3-dioxygenase) inhibitors pipeline analysis report includes ongoing clinical and non-clinical trends in the global IDO inhibitors market. Most of the pipeline therapeutics are in early stage of development, the market is yet to witness first IDO inhibitor launch and its impact on overall oncology market. Indoleamine-2,3-dioxygenase (IDO) is one of the many immune checkpoints in tumor immune escape. Inhibiting IDO will help researchers restore immune system responses, which in turn, will help identify and destroy cancer cells. In addition to transforming the approach to treat advanced melanoma, the successful entry of IDO inhibitors in the market will also help transform the treatment of non-small lung cancer, triple-negative breast cancer, and bladder cancer with the existing therapies. Currently, most of the IDO inhibitors under investigation are in the very nascent development stage and focusing on R&D, pharmaceutical companies are making huge investments through collaboration agreements. For instance, one of the major pharmaceutical companies Pfizer has partnered with iTeos Therapeutics for the development of undisclosed IDO1 and tryptophan 2,3-dioxygenase 2 (TDO2) inhibitors. The global IDO Inhibitors market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on IDO Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall IDO Inhibitors market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Pfizer Bristol-Myers Squibb Kyowa Hakko Kirin ... Segment by Regions North America Europe China Japan Segment by Type Dual IDO1/TDO inhibitors Covalent IDO inhibitors Segment by Application Metastatic Melanoma Metastatic Pancreatic Cancer mCRPC Malignant Glioma Astrocytoma Breast Cancer

Table of Contents

Executive Summary
1 IDO Inhibitors Market Overview
    1.1 Product Overview and Scope of IDO Inhibitors
    1.2 IDO Inhibitors Segment by Type
        1.2.1 Global IDO Inhibitors Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Dual IDO1/TDO inhibitors
        1.2.3 Covalent IDO inhibitors
    1.3 IDO Inhibitors Segment by Application
        1.3.1 IDO Inhibitors Consumption Comparison by Application (2014-2025)
        1.3.2 Metastatic Melanoma
        1.3.3 Metastatic Pancreatic Cancer
        1.3.4 mCRPC
        1.3.5 Malignant Glioma
        1.3.6 Astrocytoma
        1.3.7 Breast Cancer
    1.4 Global IDO Inhibitors Market by Region
        1.4.1 Global IDO Inhibitors Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global IDO Inhibitors Market Size
        1.5.1 Global IDO Inhibitors Revenue (2014-2025)
        1.5.2 Global IDO Inhibitors Production (2014-2025)

2 Global IDO Inhibitors Market Competition by Manufacturers
    2.1 Global IDO Inhibitors Production Market Share by Manufacturers (2014-2019)
    2.2 Global IDO Inhibitors Revenue Share by Manufacturers (2014-2019)
    2.3 Global IDO Inhibitors Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers IDO Inhibitors Production Sites, Area Served, Product Types
    2.5 IDO Inhibitors Market Competitive Situation and Trends
        2.5.1 IDO Inhibitors Market Concentration Rate
        2.5.2 IDO Inhibitors Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global IDO Inhibitors Production Market Share by Regions
    3.1 Global IDO Inhibitors Production Market Share by Regions
    3.2 Global IDO Inhibitors Revenue Market Share by Regions (2014-2019)
    3.3 Global IDO Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
    3.4 North America IDO Inhibitors Production
        3.4.1 North America IDO Inhibitors Production Growth Rate (2014-2019)
    ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form